Document Detail


Effect of cyclooxygenase-2 inhibitors on blood pressure.
MedLine Citation:
PMID:  12639178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the effect of cyclooxygenase-2 selective inhibitors (CSIs) on blood pressure. DATA SOURCES: Clinical literature accessed through MEDLINE (1966-May 2002). Key search terms included COX-2 selective inhibitors; anti-inflammatory agents, nonsteroidal; celecoxib; rofecoxib; and hypertension. DATA SYNTHESIS: Data from prospective studies on the effects of CSIs on blood pressure are conflicting. Several studies have reported increased blood pressure as an adverse effect of CSIs. CONCLUSIONS: Additional studies are needed to evaluate the effects of CSIs on blood pressure. CSIs should be used with caution in hypertensive patients and blood pressure monitored closely if a CSI is indicated.
Authors:
Deanna L Johnson; Tina M Hisel; Beth Bryles Phillips
Related Documents :
3275838 - A simple technique for multiorgan preservation.
3730158 - Clinical evaluation of a flat plate dialyzer equipped with a polycarbonate polyether co...
14767978 - Targeting portal pressure measurements: a critical reappraisal.
7485008 - Relationship between directly measured portal pressure gradient and variceal hemorrhage.
9323738 - Does the change of anterior chamber depth or/and episcleral venous pressure cause intra...
3904528 - Inspiratory work with and without continuous positive airway pressure in patients with ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  37     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-03-17     Completed Date:  2003-06-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  442-6     Citation Subset:  IM    
Affiliation:
University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*,  therapeutic use
Blood Pressure / drug effects*
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors / pharmacology*,  therapeutic use
Humans
Hypertension / drug therapy
Isoenzymes / antagonists & inhibitors
Lactones / pharmacology,  therapeutic use
Membrane Proteins
Prostaglandin-Endoperoxide Synthases
Pyrazoles
Randomized Controlled Trials as Topic
Sulfonamides / pharmacology,  therapeutic use
Sulfones
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Cyclooxygenase 2 Inhibitors; 0/Cyclooxygenase Inhibitors; 0/Isoenzymes; 0/Lactones; 0/Membrane Proteins; 0/Pyrazoles; 0/Sulfonamides; 0/Sulfones; 0/rofecoxib; 169590-42-5/celecoxib; EC 1.14.99.1/Cyclooxygenase 2; EC 1.14.99.1/PTGS2 protein, human; EC 1.14.99.1/Prostaglandin-Endoperoxide Synthases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety of selegiline with cold medications.
Next Document:  Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized...